Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014:2014:513160.
doi: 10.1155/2014/513160. Epub 2014 Apr 7.

Multiple sclerosis and pregnancy: current considerations

Affiliations
Review

Multiple sclerosis and pregnancy: current considerations

Ioan Buraga et al. ScientificWorldJournal. 2014.

Abstract

Multiple sclerosis is the most common neurological disease of young adults that causes major disability. In Romania, it is estimated that this disease has a prevalence of 35-40 per 100,000 inhabitants. It is a disease that begins at the age of 20-40 years and is 2-3 times more common in women than in men. More than half of patients with MS develop the disease in their fertile period of life; therefore, MS patients use contraceptive methods while being under our treatment. Since several therapeutic options have been implemented with good efficiency in the disease stabilization, increasingly more patients begin to wonder about the possibility of having a child and about the possible risks of pregnancy. The evolution during pregnancy and the lactation period has been favorable, with lower relapses and side effects comparable to those in the general population. In addition, babies born to mothers with MS have not had a significantly different mean gestational age or birth weight compared to babies born to healthy mothers.

PubMed Disclaimer

References

    1. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. The New England Journal of Medicine. 1998;339(5):285–291. - PubMed
    1. Giannini M, Portaccio E, Ghezzi A, et al. Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study. BMC Neurology. 2012;12(article 124) - PMC - PubMed
    1. Amato MP, Portaccio E, Ghezzi A, et al. Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis. Neurology. 2010;75(20):1794–1802. - PubMed
    1. Ferrero S, Pretta S, Ragni N. Multiple sclerosis: management issues during pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2004;115:3–9. - PubMed
    1. Tomczyk S, Wallace K, Liu S, Sperling B. Pregnancy outcomes from the Avonex (interferon beta-1a) pregnancy exposure registry. Proceedings of the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; 2012.

Substances

LinkOut - more resources